AI, Longevity & Mental Health: The Innovation Edge

by Grace Chen

digital Health in 2025: AI and Longevity Surge as Climate Innovation Lags

The digital health sector experienced a year of stark contrasts in 2025, with rapid advancements in artificial intelligence and longevity care overshadowed by stagnation in climate health solutions, according to the latest Rock Health Innovation Maturity Curve. Rising healthcare costs and increased consumer demand are driving these shifts, while regulatory hurdles loom for emerging technologies.

The digital health landscape in 2025 was defined by acceleration in consumer-facing technologies and a continued struggle to address systemic environmental health challenges. Rock Health’s analysis, tracking research, funding, and partnerships, reveals a clear divergence between areas gaining traction and those remaining largely hype.

The New Heavyweights: Mental health AI and Longevity

Two categories emerged as leaders in 2025, attracting notable investment and attention.

AI Chatbots for Mental Health: A Sector Under Scrutiny

AI chatbots for mental health became a focal point in 2025, despite ethical concerns that led to the shutdown of some early ventures. Investor confidence remains strong in purpose-built solutions, however. Slingshot’s $93 million raise signaled robust market confidence, and established players like talkspace and Lyra expanded their AI capabilities.

however, the proliferation of general-purpose chatbots offering emotional support has drawn increased regulatory scrutiny. “The FDA is increasingly questioned on where these tools fit within clinical care,” one analyst noted. The future of this sector hinges on navigating these complex regulatory challenges.

Longevity Tech: Beyond Diagnostics

Longevity technology is moving beyond simple diagnostics, aiming to provide ongoing care anchored in personalized biological baselines. Function Health’s $298 million raise,valuing the company at $2.5 billion, demonstrated the growing consumer appeal of these diagnostics.

The challenge now lies in translating the vast amount of hormonal and metabolic data collected into actionable guidance. As a senior official stated, “The ‘diagnostic land grab’ is over; the next hurdle is turning data into concrete steps consumers will actually follow.” .

Wearables Mature: From Novelty to Mainstream

Next-generation wearable form factors transitioned from an emerging trend to a developing market in 2025.

Smart rings, led by Oura, experienced explosive growth, with the company raising a historic $900 million at a nearly $11 billion valuation and selling more rings in a single year then in the previous decade combined. Other companies are expanding form factors, with Apple adding heart rate monitoring to AirPods and startups like Lumia introducing biometric earrings. A clear divide is forming between companies pursuing FDA approval for diagnostic capabilities and those operating in the unregulated “wellness” space.

Climate Health Innovation: A Stalled Sector

Despite the escalating urgency of climate change, climate health innovation remained nascent for the second consecutive year.

The sector saw virtually no new investments or enterprise partnerships within the U.S. in 2025. Policy headwinds, including environmental regulatory rollbacks, further hampered progress, pushing venture activity offshore. Rock Health suggests that successful business models must shift from abstract monitoring to tangible outcomes, such as automated interventions for high-risk asthma patients during air quality spikes. .

Health Benefits 2.0: An Economic Response

Rising healthcare premiums and cuts to public programs like Medicaid spurred a new wave of “Health benefits 2.0”.

Startups supporting Individual Coverage Health Reimbursement Arrangements (ICHRAs) experienced a breakout year, with companies like Thatch ($40 million) and Venteur ($20 million) securing significant funding. The outlook suggests a shift towards a marketplace of adjacent solutions, rather than a single, comprehensive benefits plan, as costs increasingly fall on consumers.

As the industry looks ahead to 2026, regulatory scrutiny on AI and data governance will be critical in determining whether these emerging technologies can scale safely or face significant obstacles.

Leave a Comment